Michael Icardi

1.3k total citations
23 papers, 781 citations indexed

About

Michael Icardi is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Michael Icardi has authored 23 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Michael Icardi's work include SARS-CoV-2 and COVID-19 Research (2 papers), Acute Myeloid Leukemia Research (2 papers) and BRCA gene mutations in cancer (2 papers). Michael Icardi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), Acute Myeloid Leukemia Research (2 papers) and BRCA gene mutations in cancer (2 papers). Michael Icardi collaborates with scholars based in United States and Australia. Michael Icardi's co-authors include Warren N. Schmidt, Anton P. McCaffrey, Sarmistha Bandyopadhyay, Rebecca T. Marquez, Kathy Keck, Kyle E. Brown, Erik Wendlandt, Randolph N. Christensen, Barbara Stewart and Christopher B. Burge and has published in prestigious journals such as Hepatology, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Michael Icardi

20 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Icardi United States	11	295	251	226	153	111	23	781
Zengyan Wang China	17	300 1.0×	161 0.6×	303 1.3×	67 0.4×	112 1.0×	26	905
Jong‐Da Lian Taiwan	17	116 0.4×	76 0.3×	225 1.0×	159 1.0×	62 0.6×	45	804
Yafei Zhang China	14	159 0.5×	53 0.2×	103 0.5×	102 0.7×	150 1.4×	44	706
Marta Spreafico Italy	19	157 0.5×	40 0.2×	158 0.7×	140 0.9×	69 0.6×	38	976
Olivier Romano France	10	254 0.9×	93 0.4×	159 0.7×	169 1.1×	82 0.7×	14	827
John S. Pedersen Australia	14	261 0.9×	77 0.3×	173 0.8×	93 0.6×	87 0.8×	22	911
Atsuo Maruta Japan	19	217 0.7×	50 0.2×	182 0.8×	75 0.5×	107 1.0×	67	1.5k
Dominique Challine France	18	103 0.3×	30 0.1×	267 1.2×	199 1.3×	141 1.3×	34	1.1k
Olga Millán Spain	18	142 0.5×	57 0.2×	159 0.7×	106 0.7×	187 1.7×	46	852
Jordan J. Karlitz United States	16	194 0.7×	168 0.7×	135 0.6×	83 0.5×	33 0.3×	49	1.1k

Countries citing papers authored by Michael Icardi

Since Specialization

Citations

This map shows the geographic impact of Michael Icardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Icardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Icardi more than expected).

Fields of papers citing papers by Michael Icardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Icardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Icardi. The network helps show where Michael Icardi may publish in the future.

Co-authorship network of co-authors of Michael Icardi

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Icardi. A scholar is included among the top collaborators of Michael Icardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Icardi. Michael Icardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sharma, Aditya, Gina Oda, Michael Icardi, L Molé, & Mark Holodniy. (2021). Implementation of large-scale laboratory-based detection of COVID-19 in the Veterans Health Administration, March 2020 – February 2021. Diagnostic Microbiology and Infectious Disease. 102(3). 115617–115617. 2 indexed citations

Icardi, Michael, et al.. (2021). VA-Wide, Multicenter Verification Study of the Cepheid Xpert SARS-CoV-2 Assay. Academic Pathology. 8. 2466111303–2466111303.

Fitzpatrick, Margaret A., Katie J. Suda, Swetha Ramanathan, et al.. (2019). Laboratory practices for identification and reporting of carbapenem-resistant Enterobacteriaceae in Department of Veterans Affairs facilities. Infection Control and Hospital Epidemiology. 40(4). 463–466. 5 indexed citations

Beste, Lauren A., Michael Icardi, Christine M. Hunt, et al.. (2019). Alanine Aminotransferase Results Differ by Analyzer Manufacturer in a National Integrated Health Setting, 2012–2017. Archives of Pathology & Laboratory Medicine. 144(6). 748–754. 2 indexed citations

Chanfreau‐Coffinier, Catherine, Leland E. Hull, Julie A. Lynch, et al.. (2019). Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users. JAMA Network Open. 2(6). e195345–e195345. 100 indexed citations

Hull, Leland E., Julie A. Lynch, Brygida Berse, et al.. (2017). Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant Care. Clinical Breast Cancer. 18(2). 135–143. 3 indexed citations

Efimova, Olga, Brygida Berse, Scott L. DuVall, et al.. (2017). Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration. BMC Medical Informatics and Decision Making. 17(1). 71–71. 5 indexed citations

Wang‐Rodriguez, Jessica, Ning Ma, Claudio A. Mosse, et al.. (2017). The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA.. PubMed. 34(Suppl 5). S50–S61. 1 indexed citations

Chun, Danielle S., Brygida Berse, Vickie L. Venne, et al.. (2016). BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines. Familial Cancer. 16(1). 41–49. 13 indexed citations

10.

Lenert, Petar, Michael Icardi, & Laila Dahmoush. (2013). ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review. Clinical Rheumatology. 32(7). 1099–1106. 35 indexed citations

11.

Riordan, Jesse D., et al.. (2013). The Stress-Regulated Transcription Factor CHOP Promotes Hepatic Inflammatory Gene Expression, Fibrosis, and Oncogenesis. PLoS Genetics. 9(12). e1003937–e1003937. 57 indexed citations

12.

Bandyopadhyay, Sarmistha, Robin C. Friedman, Rebecca T. Marquez, et al.. (2011). Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in Culture. The Journal of Infectious Diseases. 203(12). 1753–1762. 129 indexed citations

13.

Goldman, Frederick D., Zafer Gürel, Duha Al‐Zubeidi, et al.. (2011). Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the ikaros gene. Pediatric Blood & Cancer. 58(4). 591–597. 55 indexed citations

14.

Marquez, Rebecca T., Sarmistha Bandyopadhyay, Erik Wendlandt, et al.. (2010). Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Laboratory Investigation. 90(12). 1727–1736. 183 indexed citations

15.

Icardi, Michael, et al.. (2009). CD64 Index Provides Simple and Predictive Testing for Detection and Monitoring of Sepsis and Bacterial Infection in Hospital Patients. Journal of Clinical Microbiology. 47(12). 3914–3919. 80 indexed citations

16.

Abdalla, Maher Y., Bradley E. Britigan, Feng Wen, et al.. (2004). Down‐Regulation of Heme Oxygenase–1 by Hepatitis C Virus Infection In Vivo and by the In Vitro Expression of Hepatitis C Core Protein. The Journal of Infectious Diseases. 190(6). 1109–1118. 70 indexed citations

17.

Nishida, Seigo, Debbie Weppler, Annette R. Khaled, et al.. (2003). Sclerosing mesenteritis in small bowel transplantation: possible manifestation of acute vascular rejection. Transplantation Proceedings. 35(8). 3057–3060. 9 indexed citations

18.

Tryphonopoulos, Panagiotis, Michael Icardi, Shashikumar K. Salgar, et al.. (2002). Host-derived enterocytes in intestinal grafts. Transplantation. 74(1). 120–122. 12 indexed citations

19.

Tryphonopoulos, Panagiotis, Michael Icardi, Shashikumar K. Salgar, et al.. (2002). Male enterocytes in female intestinal grafts. Transplantation Proceedings. 34(3). 884–884. 1 indexed citations

20.

Weppler, Debbie, Michael Icardi, Alexandra Amador, et al.. (2002). Burkitt’s lymphoma variant of post-transplant lymphoproliferative disease (PTLD). Pathology & Oncology Research. 8(2). 105–108. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact